(19)
(11) EP 4 739 339 A1

(12)

(43) Date of publication:
13.05.2026 Bulletin 2026/20

(21) Application number: 24720415.9

(22) Date of filing: 05.04.2024
(51) International Patent Classification (IPC): 
A61K 39/00(2006.01)
C07K 14/47(2006.01)
A61P 35/00(2006.01)
G01N 33/53(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 39/001189; C07K 14/4748; A61P 35/00; A61K 2039/585; G01N 2500/10; G01N 2333/70578; G01N 2333/7158
(86) International application number:
PCT/EP2024/059307
(87) International publication number:
WO 2025/008085 (09.01.2025 Gazette 2025/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 05.07.2023 EP 23183516

(71) Applicant: Focus Fund-Isa LLC
Shreveport, LA 71103 (US)

(72) Inventors:
  • WIEKMEIJER, Anna-Sophia
    2342 DH Oegstgeest (NL)
  • VAN DER GRACHT, Esmé Teunisje Ida
    2342 DH Oegstgeest (NL)
  • MELIEF, Cornelis Joseph Maria
    2342 DH Oegstgeest (NL)

(74) Representative: Kirkpatrick 
Avenue Wolfers, 32
1310 La Hulpe
1310 La Hulpe (BE)

   


(54) IMMUNOTHERAPY FOR THE TREATMENT OF PRAME-EXPRESSING CANCERS